Found 6 Cervical Cancer trials
A listing of Cervical Cancer medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.
Sort by:
Featured study
The purpose of this study is to determine if you may be eligible to participate in one of ourcurrent research studies being conducted at the University of Pennsylvania. The purposes ofthese studies are to test different methods that might protect people against viruses thatcause transmittable infections or to develop better …
The purpose of this study is to investigate if minimally invasive surgery, called robotic assisted laparoscopy (small incision surgery), is better or worse than open surgery (otherwise known as a laparotomy) when performing a radical hysterectomy for cervical cancer. A radical hysterectomy is surgery to remove the uterus, cervix, the …
The NCI SHIP multi-site trial will recruit 100 individuals at Penn scheduled to undergo colposcopy to 1) evaluate self- and clinician-collected test primary HPV test accuracy by calculating clinical sensitivity and specificity for detection of CIN2+n histopathology; and 2) positive and negative percent agreement between self- and clinician-collected HPV samples.
The purpose of the study is to learn more about the illness experience of patients with cervical cancer and study the value of sharing illness experiences with patients with a new diagnosis of cervical cancer. The target populations are patients living with cervical cancer within UPHS. We plan to record …
The analysis of HPV infection, cervical lesions, and mitochondrial haplogroup diversity will provide insights into evolutionary questions by examining how mtDNA differences that have accrued over time as a result of natural selection can affect the health of modern day people. Such an analysis will also illuminate the relationships between …
The purpose of this study is to investigate the effectiveness of an investigational medication in patients with HER2-positive solid tumors that are locally advanced, unresectable, or metastatic. In this study, HER2-positive is identified as IHC 3+. The study focuses on patients who have previously received systemic treatment for their condition …
Please choose between Voice or SMS based delivery of verification code
or